Stockhub

BLIS Technologies Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 August 2022

  • curprev 09:2609:26, 26 August 2022‎ Nick talk contribs‎ 1,609 bytes +1,609‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company markets two strains of probiotic bacteria, which include BLIS K12, a probiotic supplement to support ear, nose, and throat health of infants and children, as well as for improving bad breath; and BLIS M18 for promoting the bacterial balance for dental h..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/BLIS_Technologies_Limited’